Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06643052 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator

StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Notable Primary completion date: Jun 1, 2026 to Jun 1, 2027
    • Start date: Dec 1, 2025 to Dec 1, 2026
    • Study completion date: Dec 1, 2026 to Dec 1, 2027
    v4
  2. Notable Primary completion date: Jun 1, 2025 to Jun 1, 2026
    • Start date: Dec 1, 2024 to Dec 1, 2025
    • Study completion date: Dec 1, 2025 to Dec 1, 2026
    v3
  3. Minor Secondary endpoints: details revised at 1 of 1 entryv2
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Early neonatal sepsis requires rapid and efficient intervention to prevent morbidity and mortality. Management of such a case includes invasive blood examinations, elongation of maternal and neonatal length of stay, and empiric antibiotic therapy. These actions has major side effects. On 2017, Kaiser-Permanente started using a calculator that weighs the chances for early onset neonatal sepsis, and states the best investigation and follow-up regimn for the specific newborn infant. Eversince, policy of managing neonatal suspected early onset sepsis has chaged globally, including in Israel. Current knowledge regarding the local outcome since the use of the calculatir is scarce. The goal of the study is to evaluate the change in management of suspected neonatal early onset sepsis, including its economic value, between periods before and after assimilation of the calculator in Hillel Yaffe nedica l center.
Trial Details
NCT Number NCT06643052
Lead Sponsor Hillel Yaffe Medical Center
Conditions
(from sponsor)
Neonatal Early-onset Sepsis
Related terms Neonatal Sepsis
Enrollment 6,300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov